Skip to content
Use caution Drug recall · FDA · Published August 13, 2014

Fresenius Kabi Recalls Propranolol Hydrochloride Injection Due to CGMP Deviations

Fresenius Kabi USA, LLC recalls specific lots of Propranolol Hydrochloride Injection due to CGMP deviations at the API supplier. Check your vial details.

🇺🇸 FDA recall #D-1545-2014DrugFresenius Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC2045 Cornell Ave · Melrose Park, IL 60160-1002
✎ GovInfoNow plain-language explainer

Fresenius Kabi USA, LLC is recalling Propranolol Hydrochloride Injection, USP 1 mg/mL, 1 mL Single Dose Vials. The recall stems from current Good Manufacturing Practice (CGMP) deviations identified at the API supplier by the Italian Health Agency AIFA. These deficiencies led to a recall of the active pharmaceutical ingredient lot used in this product. Read more at govinfonow.com/recall/45902-fresenius-kabi-usa-llc-recalls-propranolol-hydrochloride-injection-usp-1.

Source Summary by GovInfoNow · govinfonow.com/recall/45902-fresenius-kabi-usa-llc-recalls-propranolol-hydrochloride-injection-usp-1 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1545-2014

Cite this page

“Fresenius Kabi Recalls Propranolol Hydrochloride Injection Due to CGMP Deviations.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45902-fresenius-kabi-usa-llc-recalls-propranolol-hydrochloride-injection-usp-1. Based on FDA recall #D-1545-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1545-2014%22&limit=1).

Fresenius Kabi USA, LLC recalled Propranolol Hydrochloride Injection USP 1 mg/mL, 1 mL Single Dose Vial due to current Good Manufacturing Practice (cGMP) deviations, according to the FDA. The Food and Drug Administration announced the recall on August 13, 2014.

How to tell if you have it

  • Brand: Fresenius Kabi
  • Product: Propranolol Hydrochloride Injection, USP 1 mg/mL, 1 mL Single Dose Vial
  • NDC: 63323-604-01
  • Lot: 6007698
  • Expiration Date: 03/16
  • Quantity: 56,060 vials

The hazard

The recall stems from cGMP deviations involving citations given to the API supplier by the Italian Health Agency AIFA for critical deficiencies. These deficiencies caused a recall of the active pharmaceutical ingredient (API) lot used to manufacture the Propranolol HCl Injection.

Context

GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since September 27, 2012. Recent brand recalls include a Tyenne Injection recall for glass particles on August 10, 2026, and a Morphine Syringe labeling error on August 4, 2026. Other recent recalls of similar products include a Wells Pharma phenylephrine injectable solution recall due to cGMP deviations (April 1, 2026) and a Baxter Dexmedetomidine Injection recall for cGMP deviations risk (August 6, 2026).

How to tell if you have this one

Look for Propranolol Hydrochloride Injection, USP 1 mg/mL, 1 mL Single Dose Vial, Rx only. Check for NDC 63323-604-01, Lot 6007698, and an expiration date of 03/16.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Vial Details

    Verify if your vial matches NDC 63323-604-01, Lot 6007698, and Exp. 03/16.

  2. Contact Your Healthcare Provider

    Speak with your doctor or pharmacist about the recall and any necessary steps for replacement or disposal.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Aug 13, 201412. FDA classified it Class II: Aug 19, 201423. Published in FDA’s Enforcement Report: Aug 27, 201434. FDA terminated the recall: May 24, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Fresenius Kabi recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1545-2014 (August 13, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1545-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA